PhRMA represents the nation’s leading biopharmaceutical research companies. Our success in developing and delivering medicines to help patients live longer and healthier lives depends on ethical relationships and behavior. Browse key Codes and Guidelines below, and visit our Resource Library for more.
-
CODES & GUIDELINESEthical relationships with healthcare professionals are critical to our mission of helping patients by developing and marketing new medicines.
-
CODES & GUIDELINES-
CODES & GUIDELINESIn the era of data-driven medicine, where all parties seek more, not less, information about the safety, effectiveness, and value of treatments, fostering informed communications among all stakeholders is critical.
-
CODES & GUIDELINES-
CODES & GUIDELINES-
CODES & GUIDELINES-
Codes & GuidelinesEmerging payment and delivery reforms (often called “alternative payment models” or “value-based payment” designs) hold promise in advancing the efficient delivery of high-quality, personalized care.
-
Codes & Guidelines-
CODES & GUIDELINESIn July 2013, members of PhRMA and the European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted Principles for Responsible Clinical Trial Data Sharing.
-
Codes & GuidelinesHealthcare providers and payers are increasingly turning to clinical pathways as tools to manage the cost of care and promote evidence-based treatment.
-
CODES & GUIDELINES-
Codes & Guidelines